Long-Acting Antiretroviral Therapy Sensation
When once-a-day HIV medications became commonplace several years back, they revolutionized HIV treatment and helped make taking meds a much less intrusive part of people's daily lives.
Now just imagine what once-a-month HIV medications could do.
That pipe dream may not be so far from reality as it once seemed. This year, we learned much about a couple of "long-acting antiretroviral" candidates in the works. Most notable among these is GSK1265744 -- which, although it may need to be injected, is being engineered so that it only has to be taken once every four weeks at the most.
Early clinical trials involving these drugs have shown promising results. Now, to be sure, it's not a guarantee they'll work out, and many months of study lie ahead before we can even begin to entertain the idea that they'll become a part of regular HIV care. But it sure is an exciting concept to consider, all the more because it may be achievable.
Read the full story >>